Sustained remission of post-Fontan protein-losing enteropathy achieved by combination therapy with high-dose spironolactone and the somatostatin analogue octreotide: a case report

Abstract Background Protein-losing enteropathy (PLE) is a serious complication affecting approximately 5–12% of patients following the Fontan procedure for congenital heart disease and is associated with high mortality. Its pathophysiology is multifactorial, involving elevated central venous pressur...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Emiko Suzuki, Keisuke Jimbo, Hideo Fukunaga, Masumi Nagata, Kosuke Kashiwagi, Kaori Aoki, Nobuyasu Arai, Eri Miyata, Mitsuyoshi Suzuki, Takahiro Kudo, Hiromichi Shoji
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	BMC 2026-02-01
Edice:	BMC Pediatrics
Témata:	Fontan procedure protein-losing enteropathy spironolactone high-dose therapy octreotide somatostatin analogue
On-line přístup:	https://doi.org/10.1186/s12887-026-06671-3
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!